好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2015 Annual Meeting | 7MS.001 - Differential Diagnosis of Dementia: Linking Clinical Syndromes to Biomarkers

Friday 04/24/15
06:30 AM - 08:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Morning Seminar
Jeffrey M. Burns, MD
Participants should understand the basis for the clinical diagnoses of Alzheimer's disease in relation to dementing disorders that often mimic its presentation and should also understand the potential clinical utlility of biofluid and imaging biomarkers for Alzheimer's disease.
1.50 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Non-neurologist
Case-based, Didactic, Audience Participation
Event Timeline
06:30 AM - 06:45 AM Alzheimer's Biomarkers
Jeffrey M. Burns, MD
06:45 AM - 08:00 AM Case Studies
Jeffrey M. Burns, MD, Howard J. Rosen, MD
Faculty Disclosures
Jeffrey M. Burns, MD Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.